WallStSmart
SNOA

Sonoma Pharmaceuticals Inc

NASDAQ: SNOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.10
+3.77% today

Updated 2026-04-30

Market cap
$4.98M
P/E ratio
P/S ratio
0.28x
EPS (TTM)
$-1.95
Dividend yield
52W range
$1 – $7
Volume
0.2M

WallStSmart proprietary scores

44
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+
5.0
Quality
C+
2.0
Profitability
F
7.0
Valuation
B+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$12.00
+990.91%
12-Month target
Intrinsic (DCF)
$4.11
Margin of safety
+33.09%

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 22.00% QoQ
+ 33.09% below intrinsic value
Risks
- Thin margins at -19.00%
- Negative free cash flow $-811000.00

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$12.63M$13.27M$12.73M$14.29M$17.72M
Net income$-5.09M$-5.15M$-4.83M$-3.46M$-819000.00
EPS$-1.95
Free cash flow$-4.38M$-6.42M$-2.42M$-168000.00$-811000.00
Profit margin-40.28%-38.81%-37.97%-24.20%-19.00%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SNOA$4.98M445.32.07.05.0+33.09%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Sonoma Pharmaceuticals Inc trades at $1.10. Our Smart Value Score of 44/100 indicates the stock is fair. TTM revenue stands at $17.72M. with profit margins at -19.00%. Our DCF model estimates intrinsic value at $4.11.

Frequently asked questions

What is Sonoma Pharmaceuticals Inc's stock price?
Sonoma Pharmaceuticals Inc (SNOA) trades at $1.10.
Is Sonoma Pharmaceuticals Inc overvalued?
Smart Value Score 44/100 (Grade D, Sell). DCF value $4.11.
What is the price target of Sonoma Pharmaceuticals Inc (SNOA)?
The analyst target price is $12.00, representing +990.9% upside from the current price of $1.10.
What is the intrinsic value of Sonoma Pharmaceuticals Inc (SNOA)?
Based on our DCF model, intrinsic value is $4.11, a +33.1% margin of safety versus $1.10.
What is Sonoma Pharmaceuticals Inc's revenue?
TTM revenue is $17.72M.

Company info

SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.28x
ROE-81.20%
Beta1.76
50D MA$2.38
200D MA$3.40
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years